This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Osman, F. Articles by Franklyn, J. A. Search for Related Content PubMed PubMed Citation Articles by Osman, F. Articles by Franklyn, J. A.

Cardiac Dysrhythmias and Thyroid Dysfunction - The Hidden Menace?

Division of Medical Sciences (F.O., M.D.G., M.C.S., J.A.F.), Queen Elizabeth Hospital, University of Birmingham, Birmingham, United Kingdom B15 2TH

Address all correspondence and requests for reprints to: Prof. J. A. Franklyn, Department of Medicine, Queen Elizabeth Hospital, Birmingham B15 2TH, United Kingdom. E-mail: . J.A.Franklyn{at}bham.ac.uk

Abstract

Thyrotoxicosis is often perceived as a reversible disorder without long-term consequences, perhaps because of the availability of effective treatments, but recent evidence suggests that there may, in fact, be adverse outcomes. Long-term follow-up studies have revealed increased mortality from cardiovascular and cerebrovascular disease in those with a past history of overt hyperthyroidism treated with radioiodine as well as in those with subclinical hyperthyroidism indicated by a low serum TSH concentration. Thyroid hormones exert direct effects on the myocardium as well as the systemic vasculature predisposing to dysrhythmias, especially supraventricular. Effects of thyroid hormones on the autonomic nervous system may also contribute to arrhythmogenesis. Atrial fibrillation is a recognized complication of hyperthyroidism that predisposes to embolic events. Development of atrial fibrillation, together with other supraventricular dysrhythmias (both clinically obvious and those detected only by Holter monitoring) in those with hyperthyroidism may account for increased vascular mortality. Improved detection of supraventricular dysrhythmias and therapeutic intervention (e.g. anticoagulants, antiarrhythmics) may improve the long-term vascular prognosis, but their role remains to be established in large therapeutic trials.

This article has been cited by other articles:

				B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]

				S. Metso, P. Jaatinen, H. Huhtala, A. Auvinen, H. Oksala, and J. Salmi Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2190 - 2196. [Abstract] [Full Text] [PDF]

				P.-Q. Yuan and H. Yang Hypothyroidism increases Fos immunoreactivity in cholinergic neurons of brain medullary dorsal vagal complex in rats Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E892 - E899. [Abstract] [Full Text] [PDF]

				M. Helfand Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, January 20, 2004; 140(2): 128 - 141. [Abstract] [Full Text] [PDF]